For example, an application of pharmacological or endogenous inhibitors of Notch receptors down-regulates stemness factors (e.g., OCT4) and potentiates the efficacy of anti-cancer agents, including cisplatin and sorafenib, in renal cell carcinoma cells [121]. Here, POU5F1 is linked to cancer.